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For instance, the concomitant bioenergetic stress following CcO 
 inhibition by NO increases the AMP:ATP ratio that, by stimulating 
the AMP-activated protein kinase (AMPK), switches on glycolysis 
(Almeida et al., 2004). In addition, a reduction in cytochrome c 
is followed by the inhibition of CcO by ￿NO, and this enhances 
mitochondrial superoxide formation (O￿
2
−) that activates signaling 
pathways involved in cytoprotection (Moncada and Erusalimsky, 
2002; Moncada and Bolanos, 2006) and hypoxic effects (Palacios-
Callender et al., 2007). Moreover, during ￿NO-mediated interaction 
with CcO, O2
− formation is observed even before an inhibition of 
respiration is observed (Palacios-Callender et al., 2004; Jacobson 
et al., 2005). Interestingly, reduced cytochrome c can also react 
with  ￿NO to produce the nitroxyl anion (NO−) species (Sharpe 
and Cooper, 1998b; Parihar et al., 2008). Furthermore, either O￿
2
− 
and ￿NO (Blough and Zaﬁ  riou, 1985), or O2 and NO− (Sharpe and 
Cooper, 1998b; Parihar et al., 2008), can spontaneously react to form 
the very unstable pro-oxidant peroxynitrite anion (ONOO−). Thus, 
through the interaction of ￿NO with CcO, mitochondria become 
both the target of ￿NO and the site of peroxynitrite formation. 
However, as unraveled by other laboratories, extra-mitochondrial 
formation of peroxyntirite, for instance through the reaction of 
￿NO with plasma membrane NADPH-derived O2
− (Bal-Price et al., 
2002; Mander and Brown, 2005), can also occur.
OTHER MITOCHONDRIAL TARGETS OF PEROXYNITRITE
Regardless of the speciﬁ  c source of formation, peroxyntirite can 
easily diffuse through membranes due to its high lipid solubil-
ity (Lim et al., 2008), and hence it can reach targets distant from 
its site of production. In fact, peroxynitrite is implied in damages 
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CONTINUOUS EXPOSURE TO NITRIC OXIDE/PEROXYNITRITE
After the discovery of the potential biological roles of nitric oxide 
(￿NO) (Ignarro et al., 1987; Palmer et al., 1987), its implication as 
a key player during glutamatergic neurotransmission was shortly 
reported (Garthwaite et al., 1988). By activating soluble guanylate 
cyclase (sGC), ￿NO thus participates in the signaling cascade leading 
to activation of cyclic GMP-dependent protein kinases (Garthwaite, 
2008). Due to its multiple targets, it is now clear that ￿NO has a criti-
cal role for tissue survival, including the brain (Almeida et al., 1999; 
Pacher et al., 2007; Calabrese et al., 2009). In 1994, four independent 
laboratories reported that ￿NO, either exogenously added to several 
preparations containing mitochondria, or endogenously produced 
in intact cells, via the inducible form of ￿NO synthase (NOS2), 
inhibited cytochrome c oxidase (CcO), the terminal complex of 
the mitochondrial respiratory chain (Bolaños et al., 1994; Brown 
and Cooper, 1994; Cleeter et al., 1994; Schweizer and Richter, 1994). 
However, in the three laboratories that used exogenous ￿NO, the 
effect on CcO was found to be reversible (Brown and Cooper, 1994; 
Cleeter et al., 1994; Schweizer and Richter, 1994) and in competition 
with O2 (Brown and Cooper, 1994; Schweizer and Richter, 1994), 
whereas in the other study (Bolaños et al., 1994), which relied upon 
endogenous/sustained ￿NO formation, inhibition of CcO activity 
was found to be progressive and persistent.
The implications of the reversible interaction of CcO with ￿NO 
for cell signaling and physiology are of paramount importance 
(Levonen et al., 2001; Brookes et al., 2002; Cooper, 2002; Brown, 
2007; Taylor and Moncada, 2009), although there still remain some 
issues that may require further validation (Garthwaite, 2008). 
Persistent mitochondrial damage by nitric oxide and its 
derivatives: neuropathological implications
Juan P . Bolaños1* and Simon J. R. Heales2,3
1  Department of Biochemistry and Molecular Biology, Institute of Neurosciences of Castilla- Leon, University of Salamanca, Salamanca, Spain
2  Molecular and Genetics Unit, Institute of Child Health, University College London, London, UK
3  Department of Chemical Pathology, Great Ormond Street Hospital, London, UK
Approximately 15 years ago we reported that cytochrome c oxidase (CcO) was persistently inhibited 
as a consequence of endogenous induction and activation of nitric oxide (￿NO) synthase-2 (NOS2) 
in astrocytes. Furthermore, the reactive nitrogen species implicated was peroxynitrite. In contrast 
to the reversible inhibition by ￿NO, which occurs rapidly, in competition with O2, and has signaling 
regulatory implications, the irreversible CcO damage by peroxynitrite is progressive in nature 
and follows and/or is accompanied by damage to other key mitochondrial bioenergetic targets. 
In puriﬁ  ed CcO it has been reported that the irreversible inhibition occurs through a mechanism 
involving damage of the heme a3-CuB binuclear center leading to an increase in the Km for oxygen. 
Astrocyte survival, as a consequence of peroxynitrite exposure, is preserved due to their robust 
bioenergetic and antioxidant defense mechanisms. However, by releasing peroxynitrite to the 
neighboring neurons, whose antioxidant defense can, under certain conditions, be fragile, activated 
astrocytes trigger bioenergetic stress leading to neuronal cell death. Thus, such irreversible inhibition 
of CcO by peroxynitrite may be a plausible mechanism for the neuronal death associated with 
neurodegenerative diseases, in which the activation of astrocytes plays a crucial role.
Keywords: cytochrome c oxidase, nitric oxide, peroxynitrite, neurons, astrocytes, neurodegeneration
Edited by:
Ralf Dringen, University of Bremen, 
Germany
Reviewed by:
Vitorio Calabrese, University of Catania, 
Italy
Vera Adam-Vizi, Semmelweis 
University Budapest, Hungary
*Correspondence:
Juan P . Bolaños, Department of 
Biochemistry and Molecular Biology, 
University of Salamanca, Ediﬁ  cio 
Departamental Lab. 122, Campus 
Miguel de Unamuno, 37007 
Salamanca, Spain. 
e-mail: jbolanos@usal.esBolaños and Heales  Irreversible complex IV damage in neuropathology
Frontiers in Neuroenergetics  www.frontiersin.org  February 2010  | Volume 2  |  Article 1  |  2
to several cellular components, including essential mitochondrial 
proteins such as aconitase (Castro et  al., 1994; Gardner et  al., 
1997; Tortora et  al., 2007), NADH dehydrogenase (Radi et  al., 
1994; Borutaite et al., 2000), succinate dehydrogenase (Radi et al., 
1994), α-ketoglutarate dehydrogenase (Park et al., 1999), amongst 
other mitochondrial targets (Radi et al., 2002), DNA (Inoue and 
Kawanishi, 1995; Uppu et al., 1996; Cantoni and Guidarelli, 2008) 
and lipids (Patel and Darley-Usmar, 1996). It is now also very well 
accepted that peroxynitrite can be formed in vivo (Beal, 2002), 
and is likely to modify or damage a still undetermined number 
of proteins (Liaudet et al., 2009). The exact mechanisms whereby 
peroxynitrite interacts with proteins are not known. The most 
common reactions involve nitration of tyrosine on its position 3 
(Radi, 2004) and oxidation of sulfhydryls (Radi et al., 1991), both of 
which can modify critical structures of proteins leading to change 
in activity (most likely inactivation). In fact, immunodetection of 
3-nitrotyrosines in proteins of biological samples is now consid-
ered a good reﬂ  ection of peroxynitrite formation (Greenacre and 
Ischiropoulos, 2001; Bolanos et al., 2004). Furthermore, critical 
proteins have been shown to be both nitrosylated (i.e., nitrated on 
tyrosine residues) and oxidized (i.e., sulfhydryl oxidation), such 
as mitochondrial NADH dehydrogenase (Landino, 2008), giving 
rise to a complex way of modulation of enzyme activity that still 
requires further elucidation.
ON THE MECHANISM OF PEROXYNITRITE INTERACTION WITH 
CYTOCHROME C OXIDASE
The molecular mechanism responsible for the irreversible inhibi-
tion of CcO by peroxyntirite was ﬁ  rst investigated by Sharpe and 
Cooper (Sharpe and Cooper, 1998a). They revealed a complex inter-
action between peroxyntirite and puriﬁ  ed CcO causing an increase 
in the Km for O2 and a decrease in the Vmax of the enzyme, as well as 
spectra changes compatible with oxidation of the a3 center, partial 
reduction of cytochrome a, and irreversible damage to the CuA site 
(Sharpe and Cooper, 1998a; Pearce et al., 1999). The decrease in 
Vmax observed by Sharpe and Cooper (1998a) is compatible with 
the 25% inhibition of the speciﬁ  c activity of COX in astrocytes 
activated to endogenously produce peroxynitrite (Bolaños et al., 
1994). Regardless the speciﬁ  c mechanism leading to CcO irrevers-
ible damage by peroxynitrite, it is now clear that this interaction 
may have a still non-conceived pathophysiological implications 
(Cooper et al., 2003).
BRAIN IMPLICATIONS OF THE PEROXYNITRITE-CYTOCHROME 
C OXIDASE INTERACTION
Due to its high-energy requirements to support ionic balance 
and neurotranmission (Hertz et al., 2007; Nehlig and Coles, 2007; 
Pellerin et al., 2007; Cai and Sheng, 2009), the central nervous system 
is one of the most vulnerable targets to mitochondrial impairment. 
However, the brain is a complex tissue formed by the organization of 
four well-differentiated neural cell types, including neurons, astro-
cytes, microglia and oligodendrocytes (Hertz et al., 2007). Such cell 
types do not act in isolation, as a degree of active collaboration exists 
between the differing cells, e.g. astrocytes are involved in gluta-
mate homeostasis and the trafﬁ  cking of antioxidants to neuronal 
cells (Fellin, 2009; Perea et al., 2009). Furthermore, astrocytes and 
neurons establish a mutual paracrine-like   communication system 
through the release of soluble and cell permeable factors, involving 
cytokines (Peuchen et al., 1997), reactive oxygen and nitrogen spe-
cies (RONS) (Whitney et al., 2009) or substrate precursors (Pellerin 
et al., 2007) (Figure 1).
With regards to astrocytes, the presence of cytokines 
( interferon-γ, interleukine-1ß or tumor necrosis factor-α), immu-
nogenic neuronal proteins (S100ß) or other exogenous components 
such as viruses or bacterial endotoxins, such as lipopolysaccharide 
(LPS) trigger the transcription of a number of genes leading to 
a situation generally known as activation (Peuchen et al., 1997). 
Activated astrocytes are characterized by certain small morpho-
logical changes (Hertz et al., 2007) and by the release of RONS, 
including ￿NO and ONOO− (Peuchen et al., 1997). There are now 
a number of human diseases associated with this type of neuroin-
ﬂ  ammatory picture. These include multiple sclerosis (Nair et al., 
2008), Alzheimer’s and Parkinson’s diseases (McGeer and McGeer, 
2008; Rodriguez et al., 2009).
DIFFERENT VULNERABILITY BETWEEN NEURONS AND 
ASTROCYTES AGAINST NITROSATIVE DAMAGE
Our own previous data reported that activated atrocytes, which 
express NOS2 (Murphy et al., 1993), continuously release a consid-
erable amount of ￿NO (Brown et al., 1995), which is responsible for 
their inhibition of CcO activity (Bolaños et al., 1994). Moreover, the 
persistent inhibition of CcO (∼25% inhibition of complex activity) 
had functional consequences to mitochondrial respiration, since 
complete removal of ￿NO from the activated astrocytes signiﬁ  cantly 
reduced (by ∼18%) their rate of oxygen consumption (Brown et al., 
1995). However, these cells were shown to be highly resistant to any 
survival problem triggered by such inhibition, and the identiﬁ  ca-
tion of a NOS2-mediated increase in the rate of glucose conversion 
to lactate suggested that the ensuing mitochondrial bionergetic 
crisis was compensated by the up-regulation of glycolysis (Bolaños 
et al., 1994). In fact, further investigation into this issue has revealed 
a speciﬁ  c mechanism linking mitochondrial inhibition to glycolysis 
up-regulation by NO involving the switching on of the 5′AMP-
activated protein kinase–6-phosphofructo-2-kinase/fructose-
2,6-bisphosphatase (isoform 3) pathway in astrocytes, but not in 
neurons (Almeida et al., 2004). Thus, astrocytes are activated cells 
that can release large amounts of RONS without compromising 
their own survival. However, due to the lipid solubility nature of 
RONS, the neighboring neurons may become vulnerable targets.
In order to study the metabolic consequences of activated astro-
cytes to neurons, we used a neuronal-astrocyte co-culture system 
to more closely resemble the interaction between these two cells in 
vivo. Thus, astrocytes grown on the surface of a co-culture micro-
well membrane device were ﬁ  rst challenged to induce NOS2 by 
incubation with interferon-γ and LPS. When activated astrocytes 
produced large amounts of ￿NO, they were posed on the top of 
a neuronal culture monolayer (Bolaños et al., 1996) and further 
incubated for several time points, either in the presence or in the 
absence of the NOS inhibitor n-monomethyl-l-arginine (NMMA). 
We found that 24  h after the co-incubation period, neurons 
showed a NMMA-sensitive inhibition of CcO activity (Bolaños 
et al., 1996) that, in contrast to the damage to other components Bolaños and Heales  Irreversible complex IV damage in neuropathology
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of the   mitochondrial respiratory chain, was time-dependent and 
permanent (Stewart et al., 2000), causing a bioernergetic deﬁ  ciency 
leading to cell death (Bolaños et al., 1996). Thus, incubation of 
neurons to peroxynitrite-producing astrocytes for 24 h is followed 
by subsequent full recovery of COX activity; however, such recovery 
does not take place if the period of incubation was 48 h (Stewart 
et al., 2000). These results suggest that COX would remain inhib-
ited as long as peroxynitrite is present, hence respiration at COX 
recovers depending on the enzyme turnover rate. It should also 
be mentioned that other components of the mitochondrial respi-
ratory chain are also damaged, though at much lower extent, by 
endogenous peroxynitrite in astrocytes, including succinate-cyto-
chrome c oxidoreductase (Bolaños et al., 1994; Hargreaves et al., 
2007), and NADH-ubiquinone oxidoreductase (Bolaños et  al., 
1994). Moreover, these results clearly demonstrated that activated 
astrocytes can damage neighboring neurons through a mechanism 
in which ￿NO and/or ￿NO-derivatives are involved. However, it was 
intriguing that neurons were relatively resistant against activated 
astrocytes when compared with the high vulnerability of neurons 
if incubated, alone, with several pro-oxidant compounds (Bolaños 
et al., 1995, 1996). The role for antioxidant glutathione in neuro-
protection against the neurotoxic effects of nitric oxide was thus 
ﬁ  rst proposed (Bolaños et al., 1995, 1996).
PROTECTIVE ROLE FOR GLUTATHIONE AGAINST 
PEROXYNITRITE-MEDIATED NEURONAL DAMAGE
Incubation of neurons with exogenous peroxynitrite triggered a 
dose-dependent persistent inhibition of CcO that is not observed 
in astrocytes at identical concentrations (Bolaños et al., 1995). Such 
an effect was correlated with a deﬁ  ciency in the intracellular con-
centrations of glutathione in neurons, being astrocytes highly resist-
ant to such effect (Bolaños et al., 1995). In contrast, when neurons 
were incubated in the presence of activated astrocytes, the limited 
effect on ATP concentrations and neuronal survival suggested the 
development of a protective mechanism not existing in the neurons 
when cultured alone (Bolaños et al., 1996). By investigating this, we 
found that neurons increased their intracellular concentration of 
glutathione by the presence of either resting or activated astrocytes 
(Bolaños et al., 1996), indicating the transfer of glutathione, or its 
direct precursor, from astrocytes to neurons. The mechanism and 
implications for the transfer of this astrocyte-neuronal glutathione 
precursors has been conﬁ  rmed and studied in depth (Dringen et al., 
1999). In fact, co-incubation of neurons with glutathione-depleted 
astrocytes resulted in a much higher vulnerability of neurons against 
astrocyte-derived ￿NO and/or ONOO− (Gegg et al., 2005), suggesting 
that the astrocyte antioxidant capacity must be preserved in order 
to efﬁ  ciently protect neurons against damage. However, glutathione 
FIGURE 1 | Role for irreversible inhibition of cytochrome c oxidase in 
neurodegeneration. Peroxynitrite can be formed in astrocytes upon 
activation. In astrocytes, peroxyntrite irreversibly damages cytochrome 
c oxidase, which causes mitochondrial dysfunction. However, these cells 
compensate the energy deﬁ  ciency by activating glycolysis and survive. 
Peroxynitrite is a highly diffusible molecule, and hence it reaches neighboring 
neurons, where it irreversibly damages cytochrome c oxidase. In contrast to 
astrocytes, neurons cannot up-regulate the energy-compensating glycolysis 
and hence they die by bioenergetic crisis. Thus, the irreversible inhibition of 
cytochrome c oxidase by peroxynitrite has a critical negative effect on 
neuronal survival and may contribute to the propagation 
of neurodegeneration.Bolaños and Heales  Irreversible complex IV damage in neuropathology
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deﬁ  ciency can also be damaging to the astrocytes themselves, since 
glutathione depletion dramatically increase the susceptibility of 
astrocytes to peroxynitrite at doses that are not damaging in nor-
mal astrocytes (Barker et al., 1996). Thus, the role for intercellular 
glutathione exchange between neurons and astrocytes are currently 
considered to be a major target for neuroprotection (Vargas et al., 
2008; Miller et al., 2009; Sandhu et al., 2009).
CONCLUDING REMARKS
In conclusion, whilst the reversible modulation of CcO by ￿NO is 
of paramount importance for the physiological regulation of cell 
functions, the persistent interaction of its endogenous derivative 
peroxynitrite with this mitochondrial complex may have profound 
and permanent consequences for cell survival. This is of particu-
lar importance in the central nervous system, since neurons are 
particularly vulnerable cells against mitochondrial impairment 
(Bolaños et al., 1995), possibly due to their unability to up- regulate 
glycolysis and hence to compensate for any bioenergetic crisis 
(Bolaños et al., 1995; Herrero-Mendez et al., 2009). In addition, 
the glutathione-dependent fragile nature of neurons compromise 
their defense against the release of RONS from activated glial cells, 
which trigger permanent damage to CcO and also to other critical 
mitochondrial components. Thus, the irreversible inhibition of 
CcO by peroxynitrite may be a critical contributing factor for the 
neuronal death accompanying neurodegenerative disorders, such 
as Alzheimer’s and Parkinson’s diseases (Ebadi and Sharma, 2003; 
Atamna and Frey, 2007; Fukui and Moraes, 2008), in which CcO 
(Parker et al., 1990) and glutathione deﬁ  ciency (Perry et al., 1982), 
are hallmarks.
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